Kristin Kroeker, MD
Obstetrics & Gynecology · Fresno, CANPI 1205908969
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,197 and has fallen 58.7% since, to $495 in 2025. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$842
- Mayne Pharma Commercial LLC$608
- Daiichi Sankyo Inc.$518
- Therapeuticsmd, Inc.$259
- Astellas Pharma US Inc$243
- Pfizer$241
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,59494%
- Education$3166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $842 |
| Mayne Pharma Commercial LLC | 21 | $608 |
| Daiichi Sankyo Inc. | 33 | $518 |
| Therapeuticsmd, Inc. | 17 | $259 |
| Astellas Pharma US Inc | 6 | $243 |
| Pfizer | 13 | $241 |
| Sumitomo Pharma America, Inc. | 12 | $239 |
| Agile Therapeutics, Inc. | 10 | $207 |
| Myovant Sciences Inc. | 10 | $186 |
| Hologic Sales And Service, LLC | 9 | $183 |
| Shield Therapeutics Inc | 6 | $134 |
| Evofem Biosciences, Inc. | 6 | $106 |
| Coopersurgical, Inc. | 5 | $104 |
| Organon | 5 | $96 |
| Bayer | 4 | $85 |
| Sage Therapeutics, LLC | 5 | $82 |
| Merck | 5 | $78 |
| Lupin Inc. | 5 | $75 |
| Millicent US Inc | 3 | $71 |
| AMAG Pharmaceuticals, Inc. | 4 | $69 |
| Roche Diagnostics Corporation | 3 | $68 |
| Avion Pharmaceuticals | 4 | $54 |
| Exeltis, USA Inc. | 3 | $53 |
| Urovant Sciences Inc | 2 | $43 |
| Medicem Inc. | 3 | $40 |
| Meditrina | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Mimedx Group, Inc. | 1 | $35 |
| Scynexis, Inc. | 1 | $29 |
| Olympus America Inc. | 1 | $20 |
| Aspira Women's Health Inc | 1 | $19 |
| Octapharma USA, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$4,910 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $1,869 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fresno
- Kristopher BediFresno$41K
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.